Tanriverdi et al. found that compared with low-grade glioma patients, selectins (E, L, and P-selectins), leukocyte adhesion molecules (ALCAM), and platelet endothelial cell adhesion molecules-1 (PECAM-1) are highly expressed in patients with high-grade gliomas. This evidence concerns the gene PECAM1 and central nervous system cancer.